Assisting your company to achieve better transparency and build investors' trust
HKEX (00388) has updated Hong Kong’s listing rules to allow non-profitable biotech companies to list. SWCS, the company secretarial service provider for Ascletis Pharma Inc, reminded biotech companies to strike a balance between complying with required disclosures and protecting their intellectual properties.
This article is available in Chinese only.
Source：HKEJ
On 5th August 2022, SWCS Group has signed a strategic
Congratulations to China Graphite Group Limited (stock code:2237HK) on the
Congratulations to Deewin Tianxia Co., Ltd (stock code:2418HK) on the
Congratulations to Sinohealth Holdings Limited (stock code:2361HK) on the successful
Congratulations to Readboy Education Holding Company Limited (stock code:2385HK) on
Congratulations to Lushang Life Services Co., Ltd.(stock code:2376HK) on the
COPYRIGHT © 2019 SWCS · All Rights reserved